Invasive breast carcinoma - IARC

943. Gad A, Azzopardi JG (1975). Lobular
carcinoma of the breast: a special variant
of mucin-secreting carcinoma. J Clin
Pathol 28: 711-716.
944. Gad S, Caux-Moncoutier V, Pages-
Berhouet S, Gauthier-Villars M, Coupier I,
Pujol P, Frenay M, Gilbert B, Maugard C,
Bignon YJ, Chevrier A, Rossi A, Fricker JP,
Nguyen TD, Demange L, Aurias A,
Bensimon A, Stoppa-Lyonnet D (2002).
Significant contribution of large BRCA1
gene rearrangements in 120 French breast
and ovarian cancer families. Oncogene 21:
6841-6847.
945. Gadaleanu V, Craciun C (1987).
Malignant oncocytoma of the breast.
Zentralbl Allg Pathol 133: 279-283.
946. Gadducci A, Ferdeghini M, Prontera C,
Moretti L, Mariani G, Bianchi R, Fioretti P
(1992). The concomitant determination of
different tumor markers in patients with
epithelial ovarian cancer and benign ovarian
masses: relevance for differential diagnosis.
Gynecol Oncol 44: 147-154.
947. Gadducci A, Landoni F, Sartori E, Zola
P, Maggino T, Lissoni A, Bazzurini L, Arisio
R, Romagnolo C, Cristofani R (1996).
Uterine leiomyosarcoma: analysis of treatment
failures and survival. Gynecol Oncol
62: 25-32.
948. Gaertner EM, Farley JH, Taylor RR,
Silver SA (1999). Collision of uterine rhabdoid
tumor and endometrioid adenocarcinoma:
a case report and review of the literature.
Int J Gynecol Pathol 18: 396-401.
949. Gaffey MJ, Mills SE, Boyd JC (1994).
Aggressive papillary tumor of middle
ear/temporal bone and adnexal papillary
cystadenoma. Manifestations of von
Hippel-Lindau disease. Am J Surg Pathol
18: 1254-1260.
950. Gaffey MJ, Mills SE, Frierson HF Jr.,
Zarbo RJ, Boyd JC, Simpson JF, Weiss LM
(1995). Medullary carcinoma of the breast:
interobserver variability in histopathologic
diagnosis. Mod Pathol 8: 31-38.
951. Gagnon Y, Tetu B (1989). Ovarian
metastases of breast carcinoma. A clinicopathologic
study of 59 cases. Cancer 64:
892-898.
952. Gal R, Dekel A, Ben David M, Goldman
JA, Kessler E (1988). Granular cell
myoblastoma of the cervix. Case report. Br
J Obstet Gynaecol 95: 720-722.
953. Galant C, Mazy S, Berliere M, Mazy G,
Wallon J, Marbaix E (1997). Two schwannomas
presenting as lumps in the same
breast. Diagn Cytopathol 16: 281-284.
954. Galea MH, Blamey RW, Elston CE, Ellis
IO (1992). The Nottingham Prognostic
Index in primary breast cancer. Breast
Cancer Res Treat 22: 207-219.
955. Gamallo C, Palacios J, Moreno G,
Calvo dM, Suarez A, Armas A (1999). betacatenin
expression pattern in stage I and II
ovarian carcinomas : relationship with
beta-catenin gene mutations, clinicopathological
features, and clinical outcome.
Am J Pathol 155: 527-536.
956. Gamallo C, Palacios J, Suarez A,
Pizarro A, Navarro P, Quintanilla M, Cano A
(1993). Correlation of E-cadherin expression
with differentiation grade and histological
type in breast carcinoma. Am J
Pathol 142: 987-993.
957. Garber JE, Goldstein AM, Kantor AF,
Dreyfus MG, Fraumeni JF Jr., Li FP (1991).
Follow-up study of twenty-four families
with Li-Fraumeni syndrome. Cancer Res
51: 6094-6097.
958. Garcia-Higuera I, Taniguchi T,
Ganesan S, Meyn MS, Timmers C, Hejna J,
Grompe M, D'Andrea AD (2001).
Interaction of the Fanconi anemia proteins
and BRCA1 in a common pathway. Mol
Cell 7: 249-262.
959. Garcia A, Bussaglia E, Machin P,
Matias-Guiu X, Prat J (2000). Loss of heterozygosity
on chromosome 17q in epithelial
ovarian tumors: association with carcinomas
with serous differentiation. Int J
Gynecol Pathol 19: 152-157.
960. Garcia R, Troyas RG, Bercero EA
(1995). Mullerian adenosarcoma of the
cervix: differential diagnosis, histogenesis
and review of the literature. Pathol Int 45:
890-894.
961. Gardella C, Chumas JC, Pearl ML
(1996). Ovarian lipoma of teratomatous ori -
gin. Obstet Gynecol 87: 874-875.
962. Gardner GH, Greene RR, Peckham BM
(1948). Normal and cystic structures of the
broad ligament. Am J Obstet Gynecol 55:
917-939.
963. Garg PP, Kerlikowske K, Subak L,
Grady D (1998). Hormone replacement
therapy and the risk of epithelial ovarian
carcinoma: a meta-analysis. O b s t e t
Gynecol 92: 472-479.
964. Garrett AP, Lee KR, Colitti CR, Muto
MG, Berkowitz RS, Mok SC (2001). k-ras
mutation may be an early event in mucinous
ovarian tumorigenesis. Int J Gynecol
Pathol 20: 244-251.
965. Garrett AP, Ng SW, Muto MG, Welch
WR, Bell DA, Berkowitz RS, Mok SC (2000).
ras gene activation and infrequent mutation
in papillary serous carcinoma of the
peritoneum. Gynecol Oncol 77: 105-111.
966. Garzetti GG, Ciavattini A, Goteri G,
Stramazzoti D, Fabris G, Mannello B,
Romanini C (1996). Proliferating cell
nuclear antigen (PCNA) immunoreactivity
in stage I endometrial cancer: A new prognostic
factor. Int J Gynecol Cancer 6: 186-
192.
967. Garzetti GG, Ciavattini A, Goteri G,
Menzo S, de Nictolis M, Clementi M,
Brugia M, Romanini C (1994). Vaginal
micropapillary lesions are not related to
human papillomavirus infection: in situ
hybridization and polymerase chain reaction
detection techniques. Gynecol Obstet
Invest 38: 134-139.
968. Gatalica Z, Norris BA, Kovatich AJ
(2000). Immunohistochemical localization
of prostate-specific antigen in ductal
epithelium of male breast. Potential diagnostic
pitfall in patients with gynecomastia.
Appl Immunohistochem Molecul
Morphol 8: 158-161.
969. Gatchell FG, Dockerty MB, Clagett OT
(1958). Intracystic carcinoma of the breast.
Surg Gynecol Obstet 106: 347.
970. Gatta G, Lasota MB, Verdecchia A
(1998). Survival of European women with
gynaecological tumours, during the period
1978-1989. Eur J Cancer 34: 2218-2225.
971. Gatti RA, Tward A, Concannon P
(1999). Cancer risk in ATM heterozygotes:
a model of phenotypic and mechanistic differences
between missense and truncating
mutations. Mol Genet Metab 68: 419-
423.
972. Gayther SA, Mangion J, Russell P,
Seal S, Barfoot R, Ponder BA, Stratton MR,
Easton D (1997). Variation of risks of breast
and ovarian cancer associated with different
germline mutations of the BRCA2 gene.
Nat Genet 15: 103-105.
973. Gayther SA, Russell P, Harrington P,
Antoniou AC, Easton DF, Ponder BA (1999).
The contribution of germline BRCA1 and
BRCA2 mutations to familial ovarian cancer:
no evidence for other ovarian cancersusceptibility
genes. Am J Hum Genet 65:
1021-1029.
974. Gayther SA, Warren W, Mazoyer S,
Russell PA, Harrington PA, Chiano M, Seal
S, Hamoudi R, van Rensburg EJ, Dunning
AM, Love R, Evans G, Easton D, Clayton D,
Stratton MR, Ponder BAJ (1995). Germline
mutations of the BRCA1 gene in breast and
ovarian cancer families provide evidence
for a genotype-phenotype correlation. Nat
Genet 11: 428-433.
975. Gehrig PA, Groben PA, Fowler WC Jr.,
Walton LA, Van Le L (2001). Noninvasive
papillary serous carcinoma of the
endometrium. Obstet Gynecol 97: 153-157.
976. Geisler S, Lonning PE, Aas T, Johnsen
H, Fluge O, Haugen DF, Lillehaug JR,
Akslen LA, Borresen-Dale AL (2001).
Influence of TP53 gene alterations and c-
erbB-2 expression on the response to
treatment with doxorubicin in locally
advanced breast cancer. Cancer Res 61:
2505-2512.
977. Genest DR (2001). Partial hydatidiform
mole: clinicopathological features, differential
diagnosis, ploidy and molecular
studies, and gold standards for diagnosis.
Int J Gynecol Pathol 20: 315-322.
978. Genest DR, Laborde O, Berkowitz RS,
Goldstein DP, Bernstein MR, Lage J (1991).
A clinicopathologic study of 153 cases of
complete hydatidiform mole (1980-1990):
histologic grade lacks prognostic significance.
Obstet Gynecol 78: 402-409.
979. Geng L, Connolly DC, Isacson C, Ronnett
BM, Cho KR (1999). Atypical immature metaplasia
(AIM) of the cervix: is it related to
high-grade squamous intraepithelial lesion
(HSIL)? Hum Pathol 30: 345-351.
980. Gentile G, Formelli G, Pelusi G,
Flamigni C (1997). Is vestibular micropapillomatosis
associated with human papillomavirus
infection? Eur J Gynaecol Oncol
18: 523-525.
981. Geoffroy-Perez B, Janin N, Ossian K,
Lauge A, Croquette MF, Griscelli C, Debre
M, Bressac-de-Paillerets B, Aurias A,
Stoppa-Lyonnet D, Andrieu N (2001).
Cancer risk in heterozygotes for ataxiatelangiectasia.
Int J Cancer 93: 288-293.
982. Georgiannos SN, Chin Aleong J,
Goode AW, Sheaff M (2001). Secondary
Neoplasms of the Breast: A survey of the
20th Century. Cancer 92: 2259-2266.
983. Geraads A, Tary P, Cloup N (1991).
[Demons-Meigs syndrome caused by
ovarian goiter]. Rev Pneumol Clin 47: 194-
196.
984. Gerald WL, Miller HK, Battifora H,
Miettinen M, Silva EG, Rosai J (1991). Intraabdominal
desmoplastic small round-cell
tumor. Report of 19 cases of a distinctive
type of high-grade polyphenotypic malignancy
affecting young individuals. Am J
Surg Pathol 15: 499-513.
985. Gernow A, Ahrentsen OD (1989).
Adenoid cystic carcinoma of the
endometrium. Histopathology 15: 197-198.
986. Gersell DJ, Fulling KH (1989). Localized
neurofibromatosis of the female genitourinary
tract. Am J Surg Pathol 13: 873-878.
987. Gersell DJ, Katzenstein AL (1981).
Spindle cell carcinoma of the breast. A
clinocopathologic and ultrastructural
study. Hum Pathol 12: 550-561.
988. Gersell DJ, King TC (1988). Papillary
cystadenoma of the mesosalpinx in von
Hippel-Lindau disease. Am J Surg Pathol
12: 145-149.
989. Gershenson DM, del Junco G, Silva
EG, Copeland LJ, Wharton JT, Rutledge FN
(1986). Immature teratoma of the ovary.
Obstet Gynecol 68: 624-629.
990. Ghadially FN (1985). D i a g n o s t i c
Electron Microscopy of Tumors. Butterworth
& Company: London.
991. Ghazali S (1973). Embryonic rhabdomyosarcoma
of the urogenital tract. Br
J Surg 60: 124-128.
992. Giannacopoulos K, Giannacopoulou C,
Matalliotakis I, Neonaki M, Papanicolaou
N, Koumantakis E (1998). Pseudo-Meigs'
syndrome caused by paraovarian fibroma.
Eur J Gynaecol Oncol 19: 389-390.
993. Giannotti FO, Miiji LN, Vainchenker M,
Gordan AN (2001). Breast cancer with
choriocarcinomatous and neuroendocrine
features. Sao Paulo Med J 119: 154-155.
994. Giardini R, Piccolo C, Rilke F (1992).
Primary non-Hodgkin's lymphomas of the
female breast. Cancer 69: 725-735.
995. Gibbons D, Leitch M, Coscia J,
Lindberg G, Molberg K, Ashfaq R,
Saboorian MH (2000). Fine Needle
Aspiration Cytology and Histologic
Findings of Granular Cell Tumor of the
Breast: Review of 19 Cases with
Clinical/Radiologic Correlation. Breast J 6:
27-30.
996. Gil-Moreno A, Garcia-Jimenez A,
Gonzalez-Bosquet J, Esteller M, Castellvi-
Vives J, Martinez Palones JM, Xercavins J
(1997). Merkel cell carcinoma of the vulva.
Gynecol Oncol 64: 526-532.
997. Gilbey S, Moore DH, Look KY, Sutton
GP (1997). Vulvar keratoacanthoma. Obstet
Gynecol 89: 848-850.
998. Gilchrist KW, Gould VE, Hirschl S,
Imbriglia JE, Patchefsky AS, Penner DW,
Pickren J, Schwartz IS, Wheeler JE,
Barnes JM, Mansour EG (1982).
Interobserver variation in the identification
of breast carcinoma in intramammary lymphatics.
Hum Pathol 13: 170-172.
999. Gilchrist KW, Gray R, Fowble B,
Tormey DC, Taylor SG (1993). Tumor necrosis
is a prognostic predictor for early
recurrence and death in lymph node-positive
breast cancer: a 10-year follow-up
study of 728 Eastern Cooperative Oncology
Group patients. J Clin Oncol 11: 1929-1935.
1000. Gilks CB, Alkushi A, Yue JJ, Lanvin D,
Ehlen TG, Miller DM (2003). Advancedstage
serous borderline tumors of the
ovary: a clinicopathological study of 49
cases. Int J Gynecol Pathol 22: 29-36.
1001. Gilks CB, Bell DA, Scully RE (1990).
Serous psammocarcinoma of the ovary
and peritoneum. Int J Gynecol Pathol 9:
110-121.
1002. Gilks CB, Clement PB, Hart WR,
Young RH (2000). Uterine adenomyomas
excluding atypical polypoid adenomyomas
and adenomyomas of endocervical type: a
clinicopathologic study of 30 cases of an
underemphasized lesion that may cause
diagnostic problems with brief consideration
of adenomyomas of other female genital
tract sites. Int J Gynecol Pathol 19: 195-
205.
1003. Gilks CB, Clement PB, Wood WS
(1989). Trichoblastic fibroma. A clinicopathologic
study of three cases. Am J
Dermatopathol 11: 397-402.
References 387